|
gptkbp:instanceOf
|
gptkb:drug
recombinant human luteinizing hormone
|
|
gptkbp:administeredBy
|
injection
|
|
gptkbp:approvedBy
|
gptkb:European_Medicines_Agency
|
|
gptkbp:ATCCode
|
gptkb:G03GA07
|
|
gptkbp:CASNumber
|
145968-13-2
|
|
gptkbp:contraindication
|
pregnancy
primary ovarian failure
hypersensitivity to lutropin alfa
ovarian, uterine, or breast cancer
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
lutropin alfa
|
|
gptkbp:indication
|
women with severe LH and FSH deficiency
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:macromoleculeType
|
gptkb:protein
|
|
gptkbp:marketedAs
|
gptkb:Luveris
|
|
gptkbp:orthologIn
|
human luteinizing hormone
|
|
gptkbp:pregnancyCategory
|
X
|
|
gptkbp:producedBy
|
gptkb:Merck_Serono
|
|
gptkbp:routeOfAdministration
|
subcutaneous
|
|
gptkbp:sideEffect
|
abdominal pain
headache
ovarian hyperstimulation syndrome
|
|
gptkbp:subunit
|
alpha subunit
beta subunit
|
|
gptkbp:target
|
luteinizing hormone receptor
|
|
gptkbp:UNII
|
6Z1Y2V4A6Z
|
|
gptkbp:usedFor
|
treatment of infertility
stimulation of follicular development
|
|
gptkbp:bfsParent
|
gptkb:Luveris
gptkb:Pergoveris
|
|
gptkbp:bfsLayer
|
6
|